Songling Xuemaikang Capsules for mild high blood pressure
Part of Heart & circulation clinical trials.
This study tests whether Songling Xuemaikang Capsules can help lower blood pressure in people with mild hypertension who are not currently on regular medication. It may offer a natural treatment option for managing early-stage high blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 65 years old.
- You have been diagnosed with mild (Grade 1) high blood pressure.
- You are not taking blood pressure medicine regularly, or you don't take any at all.
- You are willing to sign a consent form agreeing to join the study.
- You do not have serious liver, kidney, or other major health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a Chinese herbal product called Songling Xuemaikang to see if it can help lower blood pressure and improve sleep in people who have both hypertension and insomnia. It may be an option for those not fully controlled on their current blood pressure medicine.
This trial tests whether an herbal capsule called Songling Xuemaikang can help people with brain changes caused by small vessel disease, such as white matter lesions or small strokes. It may improve symptoms like headache or dizziness in people with high blood pressure.
This trial tests whether a traditional Chinese herbal medicine called Yufeng Ningxin can help lower blood pressure in adults with newly diagnosed or ongoing high blood pressure. Researchers will measure how well it works compared to standard treatment.
This study tests a new pill that combines two blood pressure medicines to see if it can lower blood pressure more effectively in people with moderate to severe high blood pressure. If you have high blood pressure that is not well controlled, this trial might help you find a new treatment option.
This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.
This early-stage study tests a new investigational drug called QLS1410 in healthy adults and people with mild high blood pressure. The goal is to see how the drug works and if it is safe.
Hear when a new Hypertension,Essential trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.